HCPLive

How to Fix Psilocybin Trial Blinding With UMBRAA, With Josh Woolley, MD, PhD

Sep 18, 2026 · 0:06:24

Listen to Episode

✨ AI Summary

UMBRAA framework proposed to fix psilocybin trial blinding.
Single-agent placebos fail to mask psilocybin's effects.
Josh Woolley detailed the new blinding method.

Guests on This Episode

researcher · 4 podcast appearances

More from HCPLive

Subcutaneous Furosemide Bioequivalent to IV, Bioavailable Across Multiple Injection Sites

Oct 12, 2026 · 0:03:18

Targeting Senescent Cells in Actinic Keratosis With RLS-1496

Oct 12, 2026 · 0:04:25

Atopic Dermatitis Biologic Selection, With Raj Chovatiya, MD, PhD

Oct 12, 2026 · 0:03:33

Tovinontrine 50 mg Improves cGMP With Minimal Effect on NT-proBNP in HFpEF

Oct 12, 2026 · 0:06:00

View all episodes →